Literature DB >> 8427824

Assessment of area of involvement in skin disease: a study using schematic figure outlines.

S Tiling-Grosse1, J Rees.   

Abstract

The ability to assess the severity of dermatoses by measurement of area of involvement is important in both clinical practice and research. Using schematic figure outlines we have shown that physicians, nurses and other groups are unable to assess area accurately, and that the degree of error is partially dependent on absolute area, but also on other factors. The pattern and magnitude of the errors varied between the groups examined, but overall was such that it calls in question the use of area indices such as the PASI (psoriasis area and severity index) score in the assessment of inflammatory dermatoses.

Entities:  

Mesh:

Year:  1993        PMID: 8427824     DOI: 10.1111/j.1365-2133.1993.tb00150.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.

Authors:  Joerg Albrecht; Lynne Taylor; Jesse A Berlin; Samuel Dulay; Gina Ang; Steven Fakharzadeh; Jonathan Kantor; Ellen Kim; Giuseppe Militello; Karen McGinnis; Stephen Richardson; James Treat; Carmela Vittorio; Abby Van Voorhees; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2005-11       Impact factor: 8.551

2.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

3.  Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.

Authors:  Yunyoung C Chang; Victoria P Werth
Journal:  Curr Dermatol Rep       Date:  2013-01-24

Review 4.  Clinical outcome measures for cutaneous lupus erythematosus.

Authors:  J Albrecht; V P Werth
Journal:  Lupus       Date:  2010-08       Impact factor: 2.911

5.  The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Authors:  Thaschawee Arkachaisri; Soamarat Vilaiyuk; Suzanne Li; Kathleen M O'Neil; Elena Pope; Gloria C Higgins; Marilynn Punaro; Egla C Rabinovich; Margalit Rosenkranz; Daniel A Kietz; Paul Rosen; Steven J Spalding; Teresa R Hennon; Kathryn S Torok; Elaine Cassidy; Thomas A Medsger
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

6.  Reliability and convergent validity of two outcome instruments for pemphigus.

Authors:  Misha Rosenbach; Dedee F Murrell; Jean-Claude Bystryn; Sam Dulay; Sarah Dick; Steve Fakharzadeh; Russell Hall; Neil J Korman; Julie Lin; Joyce Okawa; Amit G Pandya; Aimee S Payne; Mathew Rose; David Rubenstein; David Woodley; Carmela Vittorio; Benjamin B Werth; Erik A Williams; Lynne Taylor; Andrea B Troxel; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2009-04-09       Impact factor: 8.551

7.  Scoring systems in pemphigus.

Authors:  Sanjiv Grover
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

8.  Ustekinumab biotherapy and real-time psoriasis capacitance mapping: a pilot study.

Authors:  Claudine Piérard-Franchimont; Gérald E Piérard
Journal:  J Biomed Biotechnol       Date:  2012-03-27

Review 9.  Development of outcome measures for autoimmune dermatoses.

Authors:  Elizabeth Gaines; Victoria P Werth
Journal:  Arch Dermatol Res       Date:  2007-11-06       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.